27 results match your criteria: "and the Johns Hopkins Bloomberg School of Public Health[Affiliation]"

Purpose: Many medical school curricula include Scholarly Concentrations (SC) programs. While studies have examined how these programs affect students' future research involvement, the association of SC programs with students' specialty choices is uncertain. This study examines the SC program factors associated with congruence between the specialty focus of students' SC projects and the clinical specialty they matched into for residency.

View Article and Find Full Text PDF

Protecting, promoting and supporting breastfeeding in all policies: reframing the narrative.

Front Public Health

July 2023

Department of Population, Family and Reproductive Health, Johns Hopkins University School of Nursing and The Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.

Recent research highlights the importance of breastfeeding to health across the lifecourse, yet inadequate investment to facilitate breastfeeding according to World Health Organization recommendations threatens to undermine breastfeeding's protective effects. Western media narratives often fail to convey the significance of breastfeeding, and such narratives can hinder efforts to direct sufficient resources to scaling up effective systems and generating policy change. Delayed action disproportionately harms poor and marginalized communities.

View Article and Find Full Text PDF

Racial capitalism and the US formula shortage: A policy analysis of the formula industry as a neocolonial system.

Front Sociol

October 2022

Department of Maternal and Child Health, Gillings School of Global Public Health, Carolina Global Breastfeeding Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.

The U.S. is currently experiencing a formula shortage and an infant feeding crisis that began with a formula recall and the hospitalization of 4 infants, 2 of whom died.

View Article and Find Full Text PDF

Ambulatory Surgery Centers Versus Hospital Outpatient Departments for Orthopaedic Surgeries.

J Am Acad Orthop Surg

March 2022

From the Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, Baltimore, MD (Wang, Puvanesarajah, Marrache, Ficke and, Jain), and the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (Levy).

Background: The goals of this study were to compare the utilization and costs of ambulatory surgery centers (ASCs) versus hospital outpatient department (HOPD) for commonly performed outpatient orthopaedic surgical procedures.

Methods: Commercially insured patients undergoing elective, outpatient orthopaedic surgery were queried using an administrative claims database. We queried the following surgeries: carpal tunnel release, lumbar microdiskectomy, anterior cruciate ligament reconstruction, knee arthroscopy, arthroscopic rotator cuff repair, and bunion repair.

View Article and Find Full Text PDF

Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.

N Engl J Med

December 2021

From the University of Rochester School of Medicine and Dentistry (A.R.F., M.C.K.) and Rochester Regional Health (A.R.F.), Rochester, and Vagelos College of Physicians and Surgeons, New York Presbyterian Columbia University Irving Medical Center, Department of Medicine, Division of Infectious Diseases (M.E.S.) and the New York University Vaccine Center (M.J.M.), New York - all in New York; Biometrics (I.H.) and Infectious Diseases (J.A.G.), Late-Stage Development, Respiratory and Immunology (R.P.M.), Biopharmaceuticals Research and Development (M.N.P.), AstraZeneca, Cambridge, United Kingdom; Biometrics (S.S., K.S.) and Infectious Diseases, Late-Stage Development, Respiratory and Immunology (J.M., T. Takas, T.V., A.G.-L.), Translational Medicine, Microbial Sciences, Biopharmaceuticals Research and Development (E.J.K.), and Clinical Development, Early Global Development, Oncology Research and Development (N.M.), AstraZeneca, Gaithersburg, the Walter Reed Army Institute of Research, Silver Spring (M.L.R.), the University of Maryland School of Medicine (K.M.N.) and the Johns Hopkins Bloomberg School of Public Health (A.D.), Baltimore, the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense, Edgewood (J.C.), and the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda (T. Tong, M.B.I., M.C.N.) - all in Maryland; the University of Washington (L.C., W.H.) and the Fred Hutchinson Cancer Research Center (L.C., W.H., J.H., H.E.J.), Seattle; HealthPartners Institute, St. Paul, MN (C.M.); Orlando Immunology Center, Orlando (E.D.), and JEM Headlands Research, Lake Worth Beach (L.B.) - both in Florida; Hassman Research Institute, Berlin, NJ (M.H.); the University of California San Diego, La Jolla (S.J.L.), the Lundquist Institute at Harbor-UCLA Medical Center, Torrance (E.S.D.), and the San Francisco Department of Public Health, San Francisco (S.B.) - all in California; Children's Mercy Kansas City, Kansas City, MO (B.A.P.); Tekton Research, Austin (P.P.), and Centex Studies, McAllen (J.S.) - both in Texas; Medpharmics, Albuquerque, NM (Q.O.C.); John H. Stroger, Jr. Hospital of Cook County, Chicago (T.O.); Instituto de Ciencias Biomédicas, Facultad de Medicina Universidad de Chile, Santiago, Chile (S.L.V.); Clínica Internacional Sede Lima, Lima, Peru (A.G.B.); Clinical Research Partners, Richmond, VA (R.C.); the University of Vermont Larner College of Medicine and UVM Medical Center, Burlington (B.D.K.); Mercury Street Medical Group, Butte, MT (J.P.); and the Rollins School of Public Health at Emory University, Atlanta (D.B.).

Background: The safety and efficacy of the AZD1222 (ChAdOx1 nCoV-19) vaccine in a large, diverse population at increased risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in the United States, Chile, and Peru has not been known.

Methods: In this ongoing, double-blind, randomized, placebo-controlled, phase 3 clinical trial, we investigated the safety, vaccine efficacy, and immunogenicity of two doses of AZD1222 as compared with placebo in preventing the onset of symptomatic and severe coronavirus disease 2019 (Covid-19) 15 days or more after the second dose in adults, including older adults, in the United States, Chile, and Peru.

Results: A total of 32,451 participants underwent randomization, in a 2:1 ratio, to receive AZD1222 (21,635 participants) or placebo (10,816 participants).

View Article and Find Full Text PDF

Strengthening Security for Gene Synthesis: Recommendations for Governance.

Health Secur

May 2020

Amanda Kobokovich, MPH, is an Analyst and Research Associate; Rachel West is a doctoral student; Michael Montague, PhD, is a Senior Scholar and Research Scientist; Tom Inglesby, MD, is the Center Director and Professor; and Gigi Kwik Gronvall, PhD, is a Senior Scholar and Associate Professor; all at the Johns Hopkins Center for Health Security and the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Since the inception of gene synthesis technologies, there have been concerns about possible misuse. Using gene synthesis, pathogens-particularly small viruses-may be assembled "from scratch" in the laboratory, evading the regulatory regimes many nations have in place to control unauthorized access to dangerous pathogens. Progress has been made to reduce these risks.

View Article and Find Full Text PDF

Influencing Factors in the Development of State-Level Movement Restriction and Monitoring Policies in Response to Ebola, United States, 2014-15.

Health Secur

April 2020

Mary Leinhos, PhD, MS, is a Senior Health Scientist, Office of Applied Research, Center for Preparedness and Response; Eric G. Carbone, PhD, MBA, is Chief, Disability & Health Promotion Branch, Division of Human Development and Disability; and Erin Thomas, PhD, is a Health Scientist, Program Performance and Evaluation Office; all at the Centers for Disease Control and Prevention, Atlanta, Georgia.

During the 2014-15 domestic Ebola response, US states developed monitoring and movement restriction policies for potentially exposed individuals. We describe decision-making processes and factors in the development of these policies. Results may help health officials anticipate potential concerns and policy influencers in future infectious disease responses.

View Article and Find Full Text PDF

Defining occupational latent tuberculosis infection (LTBI) risk among healthcare workers is needed to support implementation of prevention guidelines. Prospective cohort study of 200 medical residents and nursing students in India was conducted May 2016-December 2017. Tuberculin skin test (TST) and QuantiFERON TB Gold Test-in-tube (QFT-GIT) were performed at study entry and 12 months.

View Article and Find Full Text PDF

Objective: To investigate the associations of war and postconflict factors with mental health among Sierra Leone's former child soldiers as adults.

Method: In 2002, we recruited former child soldiers from lists of soldiers (aged 10-17 years) served by Disarmament, Demobilization, Reintegration centers and from a random door-to-door sample in 5 districts of Sierra Leone. In 2004, self-reintegrated child soldiers were recruited in an additional district.

View Article and Find Full Text PDF

Impact of the Affordable Care Act on trauma and emergency general surgery: An Eastern Association for the Surgery of Trauma systematic review and meta-analysis.

J Trauma Acute Care Surg

August 2019

From the Center for Surgery and Public Health (Y.A.Z., C.T., A.J.S., A.H.H.), Harvard Medical School, Harvard T. Chan School of Public Health, Brigham and Women's Hospital, Boston, Massachusetts; UCSF-East Bay Department of Surgery (Y.A.Z., C.T., A.J.S., A.H.H.), Oakland, California; Harborview Medical Center (J.W.S., B.R.H.R.), University of Washington, Seattle, Washington; Department of Epidemiology and Biostatistics (P.C-H.H.), University of Arizona, Tuscon, Arizona; University of Florida College of Medicine Jacksonville (M.C., S.C.G.), Jacksonville, Florida; UT Health-East Texas (SDG), Tyler, Texas; Department of Orthopaedic Surgery (A.J.S.), Brigham and Women's Hospital, Boston, Massachusetts, University of Kentucky (A.J.B.), Louisville, Kentucky; Howard University (E.E.C.), Washington, D.C.; University of Texas Southwestern, Parkland Memorial Hospital (A.E.), Dallas, Texas; Department of Surgery, West Virginia University (J.K.D.), Morgantown, West Virginia; University of Arizona (B.J.), Tuscon, Arizona; Baylor Scott & White Health (S.S.), Dallas, Texas; Augusta University (C.Q.W.), Augusta, Georgia; Parkland Health & Hospital System (B.H.W.), Dallas, Texas; The Johns Hopkins University School of Medicine and The Johns Hopkins Bloomberg School of Public Health (E.R.H.), Baltimore, Maryland; and Department of Surgery (A.H.H.), Brigham and Women's Hospital, Boston, Massachusetts.

Background: Trauma and emergency general surgery (EGS) patients who are uninsured have worse outcomes as compared with insured patients. Partially modeled after the 2006 Massachusetts Healthcare Reform (MHR), the Patient Protection and Affordable Care Act was passed in 2010 with the goal of expanding health insurance coverage, primarily through state-based Medicaid expansion (ME). We evaluated the impact of ME and MHR on outcomes for trauma patients, EGS patients, and trauma systems.

View Article and Find Full Text PDF

Maryland's Global Hospital Budgets--Preliminary Results from an All-Payer Model.

N Engl J Med

November 2015

From the Centers for Medicare and Medicaid Services, Washington, DC (A.P.), and Baltimore (R.R., P.H.C.); and the Department of Health Care Transformation and Strategic Planning, Johns Hopkins Medicine (J.M.C.), the Health Services Cost Review Commission (D.K.), and the Johns Hopkins Bloomberg School of Public Health (J.M.S.) - all in Baltimore.

In the first year of Maryland's experiment in setting all-payer rates for hospital services, costs were contained and the quality of care improved, though the state still has high rates of hospital admissions and per capita spending for Medicare patients.

View Article and Find Full Text PDF

Courage is not the absence of fear: responding to the Ebola outbreak in Liberia.

Glob Health Sci Pract

October 2014

United States Agency for International Development/AAAS S&T Fellow, Washington, DC, USA, and the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. While in Liberia, with the Disaster Assistance Response Team (DART) of Samaritan's Purse.

View Article and Find Full Text PDF

Effects of vaccination on invasive pneumococcal disease in South Africa.

N Engl J Med

November 2014

From the Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases (NICD), National Health Laboratory Service (NHLS) (A.G., L.G., V.Q., S.M., C.M., S.A.M., C.C.), Medical Research Council, Respiratory and Meningeal Pathogens Research Unit (A.G., L.G., S.A.M.), and Department of Science and Technology/National Research Foundation, Vaccine-Preventable Diseases (S.A.M.), University of the Witwatersrand - all in Johannesburg; the Influenza Division (S.T.) and Division of Bacterial Diseases (E.R.Z., J.R.V., C.G.W.), Centers for Disease Control and Prevention, and Hubert Department of Global Health, Rollins School of Public Health, and Division of Infectious Diseases, School of Medicine, Emory University (K.P.K.) - all in Atlanta; and the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore (K.L.O.).

Background: In South Africa, a 7-valent pneumococcal conjugate vaccine (PCV7) was introduced in 2009 with a three-dose schedule for infants at 6, 14, and 36 weeks of age; a 13-valent vaccine (PCV13) replaced PCV7 in 2011. In 2012, it was estimated that 81% of 12-month-old children had received three doses of vaccine. We assessed the effect of vaccination on invasive pneumococcal disease.

View Article and Find Full Text PDF

Objective: Previous data suggest that food allergy (FA) might be more common in inner-city children; however, these studies have not collected data on both sensitization and clinical reactivity or early-life exposures.

Methods: Children in the Urban Environment and Childhood Asthma birth cohort were followed through age 5 years. Household exposures, diet, clinical history, and physical examinations were assessed yearly; levels of specific IgE to milk, egg, and peanut were measured at 1, 2, 3, and 5 years of age.

View Article and Find Full Text PDF

Ethics and obesity prevention: ethical considerations in 3 approaches to reducing consumption of sugar-sweetened beverages.

Am J Public Health

May 2014

Nancy Kass is with the Johns Hopkins Berman Institute of Bioethics and the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. At the time of the study, Kenneth Hecht was with California Food Policy Advocates, Oakland, CA. Amy Paul is with the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins Berman Institute of Bioethics. Kerry Birnbach is with California Food Policy Advocates, Oakland, CA.

Obesity and overweight prevalence soared to unprecedented levels in the United States, with 1 in 3 adults and 1 in 6 children currently categorized as obese. Although many approaches have been taken to encourage individual behavior change, policies increasingly attempt to modify environments to have a more positive influence on individuals' food and drink choices. Several policy proposals target sugar-sweetened beverages (SSBs), consumption of which has become the largest contributor to Americans' caloric intake.

View Article and Find Full Text PDF

Background: Given the increase in medications for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness and safety to make informed choices.

Purpose: To summarize the benefits and harms of metformin, second-generation sulfonylureas, thiazolidinediones, meglitinides, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon-like peptide-1 receptor agonists, as monotherapy and in combination, to treat adults with type 2 diabetes.

Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched from inception through April 2010 for English-language observational studies and trials.

View Article and Find Full Text PDF

Fluoxetine, a selective serotonin reuptake inhibitor (SSRI), has shown favorable effects in some children with autism. There are no previous studies evaluating the connection between clinical outcome and markers of clinical response to fluoxetine treatment. We examined serum brain derived neurotrophic factor (BDNF) concentrations and serotonin transporter (SERT) binding in the medial frontal cortex and midbrain, measured by single photon emission computed tomography (SPECT) scanning, in a group of 13 autistic children and adolescents (12 males, one female; age 5-16 years), who were treated for six months with fluoxetine at a dose range of 10-40 mg/day.

View Article and Find Full Text PDF

Background: Acutely ill older persons often experience adverse events when cared for in the acute care hospital.

Objective: To assess the clinical feasibility and efficacy of providing acute hospital-level care in a patient's home in a hospital at home.

Design: Prospective quasi-experiment.

View Article and Find Full Text PDF

Weighing the evidence: trends in managed care formulary decision making.

J Clin Psychiatry

February 2004

MEDTAP International Inc., Bethesda, Md., and The Johns Hopkins Bloomberg School of Public Health, Baltimore, Md. 20814, USA.

Health plans, pharmacy benefit managers, and other organizations use drug formularies to promote quality care while controlling costs. However, restrictive formularies are often viewed as constraints on physician practice and potential barriers to optimal patient care. Reluctance to add new drugs to an established formulary is rational economic behavior.

View Article and Find Full Text PDF